Citrotech Inc. key statistics and ratios
In fiscal 2025, Citrotech Inc. had an operating margin of -692.7%, debt equal to 1.9% of equity and a current ratio of 3.42. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|
| Gross margin | — | 97.0% | 74.4% | 18.9% | 22.3% | −5.2% |
| Operating margin | — | <−999% | <−999% | −656.2% | −692.7% | <−999% |
| Net margin | — | <−999% | <−999% | −851.3% | <−999% | <−999% |
| Free-cash-flow margin | — | <−999% | −233.5% | −239.7% | −254.6% | −579.5% |
| Return on equity | — | −176.5% | — | −198.0% | — | — |
| Return on assets | −28.8% | −122.7% | −208.0% | −127.7% | −374.7% | −199.4% |
| Asset turnover | — | 0.03 | 0.11 | 0.15 | 0.24 | 0.11 |
| Current ratio | 0.01 | 0.16 | 0.75 | 0.75 | 3.42 | 8.77 |
| Debt to equity | — | 1.0% | 4.8% | 5.9% | 1.9% | 0.0% |
| Interest cover (operating income ÷ interest) | n/m | n/m | n/m | n/m | n/m | n/m |
| R&D as % of revenue | — | — | 0.0% | 1.7% | 8.3% | — |
| Capital spending as % of revenue | — | 8.5% | 0.8% | 0.0% | 8.1% | 2.7% |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | −30.0% | — | 36.3% | 46.0% | −99.7% | 20.5% | 34.6% | 3.2% |
| Operating margin | −524.4% | <−999% | −356.8% | −438.8% | <−999% | <−999% | <−999% | <−999% |
| Net margin | −612.1% | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% |
| Free-cash-flow margin | −515.0% | −887.1% | −76.4% | −196.7% | −525.6% | −562.8% | −600.2% | −635.4% |
| Current ratio | 0.53 | 0.75 | 1.01 | 0.65 | 2.44 | 3.42 | 1.97 | 8.77 |
| Debt to equity | — | 2.9% | 0.0% | 0.0% | 2.0% | 0.0% | 0.0% | 0.0% |
| R&D as % of revenue | — | — | 0.8% | 6.0% | — | — | 23.6% | 70.2% |
Financial health
- Short-term assets cover short-term liabilities $4m of assets due within a year against $420,088 of liabilities due within a year.
- Short-term assets cover long-term liabilities $4m short-term assets against $603,090 of longer-dated liabilities.
- More cash than debt $3m of cash against $0 of debt.
- Debt below 40% of shareholders' equity Debt is 0% of equity.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt No debt to cover.
- Operating profit covers interest at least five times over Operating income of −$18m against $716,435 of interest.
Moat
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.
Compare with peers
- Senestech, Inc. statistics
- Park Ha Biological Technology Co., Ltd. statistics
- Research Frontiers Inc statistics
- Zone Frontier Inc. statistics
- J-star Holding Co., Ltd. statistics
Head to head: CITR vs SNESBYAH vs CITRCITR vs REFRCITR vs ZONE
More: Specialty Chemicals stocks compared, Materials sector, rankings of US companies